Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
First Edition BOGP (0)
United Kingdom (3)
Other
Neurology/Parkinson's Disease (1)
Pharmaceutical, Biotech, Medical Device Company (0)
Regulators
Clinical study phase I